glp-1 telehealth crackdown news Telehealth Booms as Demand for GLP-1s Surges and Questions Mount About Safety, Oversight

Ozempic Knockoffs Survive Crackdown Thanks to Loophole

22.95

★★★★☆4.8 (126)

As interest in GLP-1 medication grows, scammers are tricking consumers with fake alternatives. Here's how to spot them. http://www.wyff4.com/article/weight-loss-scam-warning-fueled-by-glp-1 -hype-ai-deepfakes/69917014

27.86

★★★★★4.9 (98)

FDA Warns 30 Telehealth Companies Against Illegal Marketing of Compounded GLP-1s

27.94

★★★★★5.0 (157)

The New York Times spotlighted MEDVi. The FDA had already warned the self-proclaimed 'fastest growing company in history.'

22.45

★★★★★4.7 (84)

The FDA announced plans to take action against non-FDA-approved GLP-1 receptor agonists, a move that prompted telehealth company Hims & Hers to yank its new compounded semaglutide (Wegovy) weight-loss pill from the

23.25

★★★★★4.9 (203)

FDA Targets Telehealth Compounded GLP-1 Marketing in New Warning Letters

25.75

★★★★★5.0 (176)

Despite FDA crackdown, unapproved GLP-1s still threaten the industry

28.34

★★★★★4.8 (132)